187 related articles for article (PubMed ID: 25630491)
1. Maclurin suppresses migration and invasion of human non-small-cell lung cancer cells via anti-oxidative activity and inhibition of the Src/FAK-ERK-β-catenin pathway.
Ku MJ; Kim JH; Lee J; Cho JY; Chun T; Lee SY
Mol Cell Biochem; 2015 Apr; 402(1-2):243-52. PubMed ID: 25630491
[TBL] [Abstract][Full Text] [Related]
2. Maclurin exerts anti-cancer effects on PC3 human prostate cancer cells via activation of p38 and inhibitions of JNK, FAK, AKT, and c-Myc signaling pathways.
Lee YJ; Jung O; Lee J; Son J; Cho JY; Ryou C; Lee SY
Nutr Res; 2018 Oct; 58():62-71. PubMed ID: 30340816
[TBL] [Abstract][Full Text] [Related]
3. Timosaponin AIII inhibits migration and invasion of A549 human non-small-cell lung cancer cells via attenuations of MMP-2 and MMP-9 by inhibitions of ERK1/2, Src/FAK and β-catenin signaling pathways.
Jung O; Lee J; Lee YJ; Yun JM; Son YJ; Cho JY; Ryou C; Lee SY
Bioorg Med Chem Lett; 2016 Aug; 26(16):3963-7. PubMed ID: 27422337
[TBL] [Abstract][Full Text] [Related]
4. Enterolactone alters FAK-Src signaling and suppresses migration and invasion of lung cancer cell lines.
Chikara S; Lindsey K; Borowicz P; Christofidou-Solomidou M; Reindl KM
BMC Complement Altern Med; 2017 Jan; 17(1):30. PubMed ID: 28068967
[TBL] [Abstract][Full Text] [Related]
5. Maclurin exerts anti-cancer effects in human osteosarcoma cells via prooxidative activity and modulations of PARP, p38, and ERK signaling.
Lee YJ; Lee SY
IUBMB Life; 2021 Aug; 73(8):1060-1072. PubMed ID: 34003554
[TBL] [Abstract][Full Text] [Related]
6. Emetine inhibits migration and invasion of human non-small-cell lung cancer cells via regulation of ERK and p38 signaling pathways.
Kim JH; Cho EB; Lee J; Jung O; Ryu BJ; Kim SH; Cho JY; Ryou C; Lee SY
Chem Biol Interact; 2015 Dec; 242():25-33. PubMed ID: 26332055
[TBL] [Abstract][Full Text] [Related]
7. Oroxylin A inhibits invasion and migration through suppressing ERK/GSK-3β signaling in snail-expressing non-small-cell lung cancer cells.
Wei L; Yao Y; Zhao K; Huang Y; Zhou Y; Zhao L; Guo Q; Lu N
Mol Carcinog; 2016 Dec; 55(12):2121-2134. PubMed ID: 26741501
[TBL] [Abstract][Full Text] [Related]
8. Cycloartobiloxanthone Inhibits Migration and Invasion of Lung Cancer Cells.
Tungsukruthai S; Sritularak B; Chanvorachote P
Anticancer Res; 2017 Nov; 37(11):6311-6319. PubMed ID: 29061814
[TBL] [Abstract][Full Text] [Related]
9. Alpha-mangostin suppresses phorbol 12-myristate 13-acetate-induced MMP-2/MMP-9 expressions via alphavbeta3 integrin/FAK/ERK and NF-kappaB signaling pathway in human lung adenocarcinoma A549 cells.
Shih YW; Chien ST; Chen PS; Lee JH; Wu SH; Yin LT
Cell Biochem Biophys; 2010 Sep; 58(1):31-44. PubMed ID: 20652762
[TBL] [Abstract][Full Text] [Related]
10. Ophiopogonin D suppresses TGF-β1-mediated metastatic behavior of MDA-MB-231 breast carcinoma cells via regulating ITGB1/FAK/Src/AKT/β-catenin/MMP-9 signaling axis.
Zhu X; Wang K; Chen Y
Toxicol In Vitro; 2020 Dec; 69():104973. PubMed ID: 32818624
[TBL] [Abstract][Full Text] [Related]
11. Glabridin inhibits migration, invasion, and angiogenesis of human non-small cell lung cancer A549 cells by inhibiting the FAK/rho signaling pathway.
Tsai YM; Yang CJ; Hsu YL; Wu LY; Tsai YC; Hung JY; Lien CT; Huang MS; Kuo PL
Integr Cancer Ther; 2011 Dec; 10(4):341-9. PubMed ID: 21059620
[TBL] [Abstract][Full Text] [Related]
12. Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
Kang CG; Im E; Lee HJ; Lee EO
Bioorg Med Chem Lett; 2017 May; 27(9):1914-1918. PubMed ID: 28359791
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells via down-regulation of PI3K/Akt signaling pathway.
Lee YC; Lin HH; Hsu CH; Wang CJ; Chiang TA; Chen JH
Eur J Pharmacol; 2010 Apr; 632(1-3):23-32. PubMed ID: 20097193
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of G3BPs inhibits the growth, migration and invasion of human lung carcinoma H1299 cells by suppressing the Src/FAK-associated signaling pathway.
Zhang H; Zhang SH; He HW; Zhang CX; Yu DK; Shao RG
Cancer Gene Ther; 2013 Nov; 20(11):622-9. PubMed ID: 24157923
[TBL] [Abstract][Full Text] [Related]
15. Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer.
Lin SY; Chang HH; Lai YH; Lin CH; Chen MH; Chang GC; Tsai MF; Chen JJ
PLoS One; 2015; 10(5):e0123305. PubMed ID: 25955608
[TBL] [Abstract][Full Text] [Related]
16. Lunasin suppresses the migration and invasion of breast cancer cells by inhibiting matrix metalloproteinase-2/-9 via the FAK/Akt/ERK and NF-κB signaling pathways.
Jiang Q; Pan Y; Cheng Y; Li H; Liu D; Li H
Oncol Rep; 2016 Jul; 36(1):253-62. PubMed ID: 27175819
[TBL] [Abstract][Full Text] [Related]
17. Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
Johnson FM; Saigal B; Talpaz M; Donato NJ
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6924-32. PubMed ID: 16203784
[TBL] [Abstract][Full Text] [Related]
18. Targeting H19 by lentivirus-mediated RNA interference increases A549 cell migration and invasion.
Wang L; Sun Y; Yi J; Wang X; Liang J; Pan Z; Li L; Jiang G
Exp Lung Res; 2016 Sep; 42(7):346-353. PubMed ID: 27607135
[TBL] [Abstract][Full Text] [Related]
19. Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3-dependent invasion in resistant non-small cell lung cancer cells.
Azijli K; Yuvaraj S; Peppelenbosch MP; Würdinger T; Dekker H; Joore J; van Dijk E; Quax WJ; Peters GJ; de Jong S; Kruyt FA
J Cell Sci; 2012 Oct; 125(Pt 19):4651-61. PubMed ID: 22797920
[TBL] [Abstract][Full Text] [Related]
20. IDH-Inhibiting Small Molecule DTDQ Inhibits Migration and Invasion of A549 Human Non-Small-Cell Lung Cancer Cells via Sequential Inactivation Of ERK and P38 Signaling Pathways.
Park S; Lee J; Lee SY
Cell Biochem Biophys; 2018 Jun; 76(1-2):255-263. PubMed ID: 28321613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]